D36.9
Billable codeBenign neoplasm, unspecified site
The ICD-10 code for benign neoplasm, unspecified site is D36.9.
Documentation support
General coding-documentation guidance — not a substitute for payer-specific requirements or professional coding judgment.
- •This code describes an unspecified presentation. If the medical record documents a more specific detail (e.g. laterality, type, or affected site), a more specific sibling code should be used instead — see Related codes below.
- •As a general rule, code to the highest level of specificity supported by the documentation in the medical record.
Related codes in this category
ICD-9-CM equivalent
Informational only — GEM mappings are approximate, not guaranteed one-to-one equivalents. Verify before use in billing.
- 2299Approximate match
Associated MS-DRGs
D36.9 can serve as the principal diagnosis for these Medicare Severity Diagnosis-Related Groups.
Informational only — actual DRG assignment also depends on procedures, complications/comorbidities (CC/MCC), discharge status, and payer-specific rules not reflected here.
- DRG 814Reticuloendothelial and Immunity Disorders with MCC
- DRG 815Reticuloendothelial and Immunity Disorders with CC
- DRG 816Reticuloendothelial and Immunity Disorders without CC/MCC
- DRG 826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCC
- DRG 827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CC
- DRG 828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCC
- DRG 829Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC
- DRG 830Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures without CC/MCC
- DRG 843Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC
- DRG 844Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with CC
- DRG 845Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses without CC/MCC